NCT02289209 2025-03-06Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and NeckUniversity of PittsburghPhase 2 Completed48 enrolled 18 charts
NCT03854838 2022-04-29IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.Sun Yat-sen UniversityPhase 2 Unknown25 enrolled